Rockwell Medical Inc
NASDAQ:RMTI

Watchlist Manager
Rockwell Medical Inc Logo
Rockwell Medical Inc
NASDAQ:RMTI
Watchlist
Price: 2.13 USD -4.48%
Market Cap: 68.8m USD
Have any thoughts about
Rockwell Medical Inc?
Write Note

Rockwell Medical Inc
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Rockwell Medical Inc
Total Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Rockwell Medical Inc
NASDAQ:RMTI
Total Assets
$57.1m
CAGR 3-Years
-1%
CAGR 5-Years
3%
CAGR 10-Years
9%
Haemonetics Corp
NYSE:HAE
Total Assets
$2.5B
CAGR 3-Years
12%
CAGR 5-Years
16%
CAGR 10-Years
6%
ICU Medical Inc
NASDAQ:ICUI
Total Assets
$4.3B
CAGR 3-Years
33%
CAGR 5-Years
21%
CAGR 10-Years
23%
Align Technology Inc
NASDAQ:ALGN
Total Assets
$6.4B
CAGR 3-Years
4%
CAGR 5-Years
22%
CAGR 10-Years
21%
Lantheus Holdings Inc
NASDAQ:LNTH
Total Assets
$2B
CAGR 3-Years
34%
CAGR 5-Years
38%
CAGR 10-Years
23%
Merit Medical Systems Inc
NASDAQ:MMSI
Total Assets
$2.4B
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
12%
No Stocks Found

Rockwell Medical Inc
Glance View

Market Cap
68.8m USD
Industry
Health Care

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. The company is headquartered in Wixom, Michigan and currently employs 300 full-time employees. The firm is developing and commercializing its technology platform, Ferric Pyrophosphate Citrate (FPC) for the transformative treatments for iron deficiency in multiple disease states. The company is also a supplier of hemodialysis concentrate products to kidney dialysis clinics. The firm has developed therapies namely Triferic and Triferic AVNU from its FPC platform. The Company’s products from its FPC platform, Triferic (dialysate) and Triferic AVNU intravenous (IV), is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients. Its Triferic AVNU, is an IV formulation of Triferic, for use by hemodialysis patients. its dialysis concentrates products include CitraPure Citric Acid Concentrate, Dri-Sate Dry Acid Concentrate, RenalPure Liquid Acid Concentrate, Dry Acid Concentrate Mixer, RenalPure and SteriLyte Bicarbonate Concentrate and Ancillary products.

RMTI Intrinsic Value
1.23 USD
Overvaluation 42%
Intrinsic Value
Price

See Also

What is Rockwell Medical Inc's Total Assets?
Total Assets
57.1m USD

Based on the financial report for Sep 30, 2024, Rockwell Medical Inc's Total Assets amounts to 57.1m USD.

What is Rockwell Medical Inc's Total Assets growth rate?
Total Assets CAGR 10Y
9%

Over the last year, the Total Assets growth was 9%. The average annual Total Assets growth rates for Rockwell Medical Inc have been -1% over the past three years , 3% over the past five years , and 9% over the past ten years .

Back to Top